Guardant Health Inc (Symbol: GH) recently saw its shares rise above the average analyst target price of $145.50, trading at $149.22 per share. This surge prompts analysts to consider adjustments to their target prices based on the company’s recent performance. Currently, there are 22 different analyst targets, ranging from a low of $125.00 to a high of $190.00, with a standard deviation of $19.76.
As of now, 21 analysts rate the stock as a Strong Buy, while 2 recommend a Buy and 1 suggests holding. The average rating is 1.15, indicating a strong positive outlook among analysts. This sentiment comes after an upward trend in ratings, with the average rating improving from 1.24 just three months ago.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
